Malgorzata Kucinska

Prof. Malgorzata Kucinska

Poznan University of Medical Sciences
orcid

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2012 in Mutation Research - Reviews in Mutation Research
Verified
Journal Article
Closed access
HPHanna Piotrowska
Hanna Piotrowska
MKMalgorzata Kucinska
Malgorzata Kucinska
Marek MuriasMarek Murias
Marek Murias

27 July 2020 in Biomolecules
Verified
Journal Article
Open access
PDF file
PPPaulina Pecyna
Paulina Pecyna
JWJoanna Wargula
Joanna Wargula
Marek MuriasMarek Murias
Marek Murias
MKMalgorzata Kucinska
Malgorzata Kucinska
The concept of a scaffold concerns many aspects at different steps on the drug development path. In medicinal chemistry, the choice of relevant “drug-likeness” scaffold is a starting point for the design of the structure dedicated to specific molecular targets. For many years, the chemical uniqueness of the stilbene structure has inspired scientists from different fields such as chemistry, biology, pharmacy, and medicine. In this review, we present the outstanding potential of the stilbene-based derivatives. Naturally occurring stilbenes, together with powerful synthetic chemistry possibilities, may offer an excellent approach for discovering new structures and identifying their therapeutic targets. With the development of scientific tools, sophisticated equipment, and a better understanding of the disease pathogenesis at the molecular level, the stilbene scaffold has moved innovation in science. This paper mainly focuses on the stilbene-based compounds beyond resveratrol, which are particularly attractive due to their biological activity. Given the “fresh outlook” about different stilbene-based compounds starting from stilbenoids with particular regard to isorhapontigenin and methoxy- and hydroxyl- analogues, the update about the combretastatins, and the very often overlooked and underestimated benzanilide analogues, we present a new story about this remarkable structure.

3 March 2015 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MKMalgorzata Kucinska
Malgorzata Kucinska
PSPaulina Skupin-Mrugalska
Paulina Skupin-Mrugalska
WSWojciech Szczolko
Wojciech Szczolko
Lukasz SobottaLukasz Sobotta
Lukasz Sobotta
MSMateusz Sciepura
Mateusz Sciepura
Marek MuriasMarek Murias
Marek Murias

1 July 2017 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
JDJolanta Dlugaszewska
Jolanta Dlugaszewska
WSWojciech Szczolko
Wojciech Szczolko
TKTomasz Koczorowski
Tomasz Koczorowski
PSPaulina Skupin-Mrugalska
Paulina Skupin-Mrugalska
ATAnna Teubert
Anna Teubert
TGTomasz Gośliński
Tomasz Gośliński

20 September 2020 in ChemMedChem
Verified
Journal Article
Closed access
PDF file
JPJaroslaw Piskorz
Jaroslaw Piskorz
WPWeronika Porolnik
Weronika Porolnik
MKMalgorzata Kucinska
Malgorzata Kucinska
JDJolanta Dlugaszewska
Jolanta Dlugaszewska
Marek MuriasMarek Murias
Marek Murias
JMJadwiga Mielcarek
Jadwiga Mielcarek

29 December 2016 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
JMJustyna Mikula-Pietrasik
Justyna Mikula-Pietrasik
Paweł UruskiPaweł Uruski
Paweł Uruski
PSPatrycja Sosińska
Patrycja Sosińska
KMKonstantin Maksin
Konstantin Maksin
Hanna Piotrowska-KempistyHanna Piotrowska-Kempisty
Hanna Piotrowska-Kempisty
KKKrzysztof Książek
Krzysztof Książek
Although both incidence and aggressiveness of ovarian malignancy rise with age, the exact reason for this tendency, in particular the contribution of senescent cells, remains elusive. In this project we found that the patient’s age determines the frequency of intraperitoneal metastases of ovarian cancer. Moreover, we documented that senescent human peritoneal mesothelial cells (HPMCs) stimulate proliferation, migration and invasion of ovarian cancer cells in vitro, and that this effect is related to both the activity of soluble agents released to the environment by these cells and direct cell-cell contact. The panel of mediators of the pro-cancerous activity of senescent HPMCs appeared to be cancer cell line-specific. The growth of tumors in a mouse peritoneal cavity was intensified when the cancer cells were co-injected together with senescent HPMCs. This effect was reversible when the senescence of HPMCs was slowed down by the neutralization of p38 MAPK. The analysis of lesions excised from the peritoneum of patients with ovarian cancer showed the abundance of senescent HPMCs in close proximity to the cancerous tissue. Collectively, our findings indicate that senescent HPMCs which accumulate in the peritoneum in vivo may create a metastatic niche facilitating intraperitoneal expansion of ovarian malignancy.